Computed tomography radiogenomics: A potential tool for prediction of molecular subtypes in gastric stromal tumor

Table 1 Clinicopathological characteristics of gastrointestinal stromal tumor patients included in this study, n (%)

Characteristics	KIT exon 11 mutation (n = 192)	Without KIT exon 11 mutation (n = 39)	P value	KIT exon 11 mutation with deletions involving codons 557-558 (n = 56)	KIT exon 11 mutation without deletions involving codons 557-558 (n = 136)	P value
Gender (male)	97 (50.5)	24 (61.5)	0.223	32 (57.1)	65 (47.8)	0.268
Age	55.7 ± 11.5	53.8 ± 13.4	0.360	53.9 ± 13.5	56.4 ± 10.6	0.222
Mitosis
≤ 5/50 HPF	91 (47.4)	24 (61.5)	0.117	11 (19.6)	80 (58.8)	< 0.010
> 5/50 HPF	101 (52.6)	15 (38.5)		45 (80.4)	56 (41.2)
Risk classification
Very low	2 (1.0)	0 (0)	0.851	0 (0)	2 (1.5)	< 0.010
Low	43 (22.4)	10 (25.7)		4 (7.1)	39 (28.7)
Intermediate	59 (30.8)	13 (33.3)		7 (12.5)	52 (38.2)
High	88 (45.8)	16 (41.0)		45 (80.4)	43 (31.6)